These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 24373793)
21. Getting to the HRT of the matter. Johns Hopkins Med Lett Health After 50; 2002 Jul; 14(5):4-5, 7. PubMed ID: 12154800 [No Abstract] [Full Text] [Related]
22. Age, hormone therapy use, coronary heart disease, and mortality. Allison MA; Manson JE Menopause; 2011 Mar; 18(3):243-5. PubMed ID: 21301373 [No Abstract] [Full Text] [Related]
23. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA]. von Schoultz B Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844 [No Abstract] [Full Text] [Related]
24. Postmenopausal hormone therapy and informed consent: a call for common sense. Kauffman RP; Castracane VD; Van Hook CL J Womens Health (Larchmt); 2005 Sep; 14(7):592-4. PubMed ID: 16181015 [No Abstract] [Full Text] [Related]
25. Where are we with postmenopausal hormone therapy in 2005? Lam PM; Chung TK; Haines C Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243 [TBL] [Abstract][Full Text] [Related]
26. Clinical appraisal of the Women's Health Initiative. Speroff L J Obstet Gynaecol Res; 2005 Apr; 31(2):80-93. PubMed ID: 15771632 [No Abstract] [Full Text] [Related]
27. The Women's Health Initiative. Implications for practice. Furniss K Adv Nurse Pract; 2002 Nov; 10(11):53-5. PubMed ID: 12478949 [No Abstract] [Full Text] [Related]
28. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health. Gambacciani M; Genazzani AR Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071 [No Abstract] [Full Text] [Related]
29. [Should hormone replacement therapy for menopause be continued in diabetic women?]. Skurnik G; Touraine P Journ Annu Diabetol Hotel Dieu; 2004; ():151-60. PubMed ID: 15259313 [No Abstract] [Full Text] [Related]
30. Shock, terror and controversy: how the media reacted to the Women's Health Initiative. Brown S Climacteric; 2012 Jun; 15(3):275-80. PubMed ID: 22612615 [TBL] [Abstract][Full Text] [Related]
31. Women's health initiative. Eaker E; Hahn RA N Engl J Med; 1994 Jan; 330(1):70-1. PubMed ID: 8259163 [No Abstract] [Full Text] [Related]
32. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM; Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467 [TBL] [Abstract][Full Text] [Related]
33. Good science or good marketing? Head K Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780 [No Abstract] [Full Text] [Related]
34. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence? Salpeter S Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764 [TBL] [Abstract][Full Text] [Related]
35. One conclusion may hide another. CMAJ; 2002 Aug; 167(4):329, 331. PubMed ID: 12197679 [No Abstract] [Full Text] [Related]
36. Good news for HRT--what next? Panay N; Fenton A Climacteric; 2012 Dec; 15(6):511-2. PubMed ID: 23174019 [No Abstract] [Full Text] [Related]
38. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM; Naftolin F; Brinton EA; Judelson DR Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [TBL] [Abstract][Full Text] [Related]
39. From dearth to deluge. Marshall E Science; 2005 Jun; 308(5728):1570. PubMed ID: 15947167 [No Abstract] [Full Text] [Related]